SCLX (STOCKS)
Scilex Holding Company Common Stock
$7.900000
-0.600000 (-7.06%)
Prev close: $8.500000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Henry H. Ji
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $67.25M
- Employees
- 31
- P/E (TTM)
- -0.12
- P/B (TTM)
- -0.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-4.76 | $0.00 | +0.0000 | +0.00% |
|
Dec 2025 (Q4)
|
$-2.21 | $-0.48 | -1.7306 | -360.99% |
|
Sep 2025 (Q3)
|
$-21.05 | $-0.84 | -20.2136 | -2,416.74% |
|
Jun 2025 (Q2)
|
$-3.79 | $-0.93 | -2.8618 | -308.32% |
Financial Statements
| Revenues | $33.86M |
| Benefits Costs and Expenses | $427.46M |
| Cost Of Revenue | $13.66M |
| Costs And Expenses | $427.46M |
| Gross Profit | $133.80M |
| Nonoperating Income/Loss | -$43.32M |
| Operating Expenses | $484.08M |
| Selling, General, and Administrative Expenses | $269.86M |
| Research and Development | $21.46M |
| Other Operating Expenses | $192.76M |
| Operating Income/Loss | -$350.28M |
| Income/Loss From Continuing Operations After Tax | -$393.62M |
| Income/Loss From Continuing Operations Before Tax | -$393.62M |
| Income/Loss From Equity Method Investments | $23.05M |
| Net Income/Loss | -$381.82M |
| Net Income/Loss Attributable To Noncontrolling Interest | $11.80M |
| Net Income/Loss Attributable To Parent | -$393.62M |
| Net Income/Loss Available To Common Stockholders, Basic | -$377.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$15.96M |
| Preferred Stock Dividends And Other Adjustments | -$15.96M |
| Basic Earnings Per Share | -$40.50 |
| Diluted Earnings Per Share | -$40.50 |
| Basic Average Shares | -4,662,966 |
| Diluted Average Shares | -4,662,966 |
| Assets | $293.64M |
| Current Assets | $41.97M |
| Inventory | $4.53M |
| Other Current Assets | $37.44M |
| Noncurrent Assets | $251.67M |
| Fixed Assets | $13.38M |
| Intangible Assets | $59.81M |
| Other Non-current Assets | $178.48M |
| Liabilities | $547.71M |
| Current Liabilities | $501.75M |
| Accounts Payable | $101.58M |
| Other Current Liabilities | $400.17M |
| Noncurrent Liabilities | $45.95M |
| Equity | -$254.07M |
| Equity Attributable To Noncontrolling Interest | -$4.85M |
| Equity Attributable To Parent | -$249.22M |
| Liabilities And Equity | $293.64M |
| Net Cash Flow From Operating Activities | -$3.30M |
| Net Cash Flow From Operating Activities, Continuing | -$1.10M |
| Net Cash Flow From Investing Activities | -$4.68M |
| Net Cash Flow From Investing Activities, Continuing | -$4.68M |
| Net Cash Flow From Financing Activities | $6.77M |
| Net Cash Flow From Financing Activities, Continuing | $6.77M |
| Exchange Gains/Losses | -$1.24M |
| Net Cash Flow | -$2.45M |
| Net Cash Flow, Continuing | $979.00K |
| Comprehensive Income/Loss | -$388.79M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$388.79M |
| Other Comprehensive Income/Loss | -$12.87M |